We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+7.34%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$22.1B
AUM Growth
+$837M
Cap. Flow
-$891M
Cap. Flow %
-4.02%
Top 10 Hldgs %
11.85%
Holding
1,375
New
137
Increased
485
Reduced
440
Closed
118

Top Buys

Rank Stock Value
1
FTI icon
TechnipFMC
FTI
+$248M
2
QCOM icon
Qualcomm
QCOM
+$77.7M
3
PEP icon
PepsiCo
PEP
+$50.8M
4
ECL icon
Ecolab
ECL
+$47.9M
5
BAX icon
Baxter International
BAX
+$46.3M

Top Sells

Rank Stock Value
1
CMI icon
Cummins
CMI
+$66M
2
UBS icon
UBS Group
UBS
+$65.7M
3
AZO icon
AutoZone
AZO
+$61.6M
4
HPQ icon
HP
HPQ
+$60.5M
5
ORCL icon
Oracle
ORCL
+$60.2M

Sector Composition

Rank Sector Weight
1 Technology 16.87%
2 Healthcare 16.62%
3 Financials 12.27%
4 Consumer Discretionary 9.64%
5 Industrials 8.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DVA icon
526
DaVita
DVA
$12.2B
$6.29M 0.03%
92,532
+7,159
+8% +$474K
HBI
527
DELISTED
Hanesbrands
HBI
$6.26M 0.03%
301,561
-20,600
-6% -$437K
VRNT
528
DELISTED
Verint Systems
VRNT
$6.26M 0.03%
283,143
+138,509
+96% +$2.7M
CWB icon
529
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.5B
$6.23M 0.03%
129,520
+2,660
+2% +$126K
DB icon
530
Deutsche Bank
DB
$72.7B
$6.22M 0.03%
362,724
+55,706
+18% +$965K
BGG
531
DELISTED
Briggs & Stratton Corp.
BGG
$6.22M 0.03%
277,200
+16,600
+6% +$361K
OEF icon
532
iShares S&P 100 ETF
OEF
$20.1B
$6.22M 0.03%
59,402
BIG
533
DELISTED
Big Lots, Inc.
BIG
$6.21M 0.03%
127,500
+8,600
+7% +$434K
LPNT
534
DELISTED
LifePoint Health, Inc.
LPNT
$6.2M 0.03%
94,631
+348
+0.4% +$21.5K
OZK icon
535
Bank OZK
OZK
$5.36B
$6.17M 0.03%
118,673
+7,104
+6% +$382K
LUV icon
536
Southwest Airlines
LUV
$19.2B
$6.14M 0.03%
114,163
+14,063
+14% +$756K
GIB icon
537
CGI
GIB
$14.9B
$6.07M 0.03%
126,529
-27,425
-18% -$1.32M
PGRE
538
DELISTED
Paramount Group
PGRE
$6.01M 0.03%
371,012
-11,688
-3% -$195K
CACI icon
539
CACI
CACI
$14.1B
$5.91M 0.03%
50,420
-1,200
-2% -$149K
STOR
540
DELISTED
STORE Capital Corporation
STOR
$5.9M 0.03%
247,210
+207,310
+520% +$5.03M
QRVO icon
541
Qorvo
QRVO
$10.4B
$5.89M 0.03%
85,900
-113,000
-57% -$7.26M
ARRY
542
DELISTED
Array Biopharma Inc
ARRY
$5.86M 0.03%
655,774
-224,449
-25% -$2.39M
DAL icon
543
Delta Air Lines
DAL
$51.9B
$5.85M 0.03%
127,192
-1,919
-1% -$93.7K
ITRI icon
544
Itron
ITRI
$4.04B
$5.81M 0.03%
+95,700
New +$5.95M
CCI icon
545
Crown Castle
CCI
$31.2B
$5.77M 0.03%
61,105
+1,705
+3% +$153K
LVS icon
546
Las Vegas Sands
LVS
$26.7B
$5.73M 0.03%
100,353
+54,653
+120% +$2.97M
MELI icon
547
Mercado Libre
MELI
$92.7B
$5.71M 0.03%
27,000
-6,400
-19% -$1.25M
SSRI
548
DELISTED
Silver Standard Resources
SSRI
$5.69M 0.03%
535,966
-16,000
-3% -$169K
ACAD icon
549
Acadia Pharmaceuticals
ACAD
$4.61B
$5.66M 0.03%
164,514
-5,061
-3% -$179K
SUM
550
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$5.62M 0.03%
234,582
+101,789
+77% +$2.39M

Similar funds

Axa's Q1 2017 Portfolio in Review

As of Q1 2017, Axa held 1,375 positions worth $22.1B, up 3.9% from $21.3B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Axa withdrew a net $891M in Q1 2017, closing 118 positions and reducing 440 holdings. Its most notable exit was QIAGEN NV, an estimated $22.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Axa opened a new position in Qiagen worth $22.1M.

  • Axa's largest Q1 2017 buy was Qiagen: 720,923 shares worth $22.1M.
  • Axa added most to TechnipFMC in Q1 2017, an estimated $248M increase.
  • Axa's biggest Q1 2017 reduction was Cummins, cutting an estimated $66M.
  • Axa fully exited QIAGEN NV in Q1 2017, selling an estimated $22.3M.
  • Axa's ten largest holdings make up 12% of its $22.1B portfolio in Q1 2017.
  • Axa opened 137 new positions and closed 118 in Q1 2017.
  • Axa's portfolio value rose 3.9% quarter-over-quarter to $22.1B.

Based on Axa's 13F filing for Q1 2017, filed 11 May 2017.